Table 4:

Univariate Cox model for progression-free survival and overall survival in patients with gliomas and glioblastomas

VariablesPFSOS
HR95% CIP ValueHR95% CIP Value
Gliomas (n = 51)
    Age1.0361.009–1.063.0081.0431.014–1.073.004
    Sexa0.9570.670–1.368.8110.8960.606–1.325.582
    KPS0.9710.953–0.989.0020.9700.952–0.988.002
    CBFmax1.0051.001–1.010.0271.0030.998–1.008.244
    rCBFmax1.6701.149–2.427.0071.2460.869–1.785.232
GBM (n = 25)
    Age1.0361.002–1.072.0391.0300.994–1.067.103
    Sexa0.8510.547–1.323.8510.8700.548–1.381.555
    KPS0.9860.963–1.008.2150.9870.965–1.009.242
    CBFmax0.9970.989–1.005.4970.9930.985–1.001.070
    rCBFmax0.8650.467–1.601.6440.5630.306–1.035.065
  • a Female versus male.